Cardiovascular Disease Prevention: Clinical Trials

1 trial for Cardiovascular Disease Prevention, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Cardiovascular Disease Prevention: new trials by email Literature Review of Cardiovascular Disease Prevention trials Research Report on Cardiovascular Disease Prevention

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
Semaglutide (Rybelsus®), Placebo - HIV, Alcohol
Phase 2RecruitingVanderbilt University Medical Center2002026-04-172026-05-26

Narrower conditions

Cardiovascular Diseases (1)  ·  Cigarette Smoking (1)  ·  Smoking (1)

Broader conditions

Behavior (1)  ·  Tobacco Smoking (1)  ·  Tobacco Use (1)

Interventions

semaglutide (1)

Sponsors

Vanderbilt University Medical Center (1)

Countries

United States (1)

Top investigators

Hilary A Tindle, MD, MPH (1)

NIH funding

P60AA032176 (1)